BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25537222)

  • 1. The influence of 5-fluorouracil on activity of thymidine phosphorylase in gastric adenocarcinoma and normal adjacent tissue.
    Stashkevych M; Khomutov E; Dumanskiy Y; Matviyenko A; Zinkovych I
    Exp Oncol; 2014 Dec; 36(4):267-70. PubMed ID: 25537222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome].
    Li Y; Liu BW; DU WL; Song ZC; Zhao Q; Fan LQ; Yang JQ; Li QJ; Wang MX; Jiao ZK; Zhang ZD
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
    Schüller J; Cassidy J; Dumont E; Roos B; Durston S; Banken L; Utoh M; Mori K; Weidekamm E; Reigner B
    Cancer Chemother Pharmacol; 2000; 45(4):291-7. PubMed ID: 10755317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer.
    Nakayama Y; Inoue Y; Nagashima N; Katsuki T; Matsumoto K; Kadowaki K; Shibao K; Tsurudome Y; Hirata K; Sako T; Nagata N; Itoh H
    Anticancer Res; 2005; 25(6A):3755-61. PubMed ID: 16302736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of thymidine phosphorylase in tumor tissue in proportion to TP-expression in primary normal tissue.
    Hotta T; Taniguchi K; Kobayashi Y; Johata K; Sahara M; Naka T; Watanabe T; Ochiai M; Tanimura H; Tsubota YT
    Oncol Rep; 2004 Sep; 12(3):539-41. PubMed ID: 15289834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thymidine phosphorylase in the induction of early growth response protein-1 and thrombospondin-1 by 5-fluorouracil in human cancer carcinoma cells.
    Matsushita S; Ikeda R; Nishizawa Y; Che XF; Furukawa T; Miyadera K; Tabata S; Ushiyama M; Tajitsu Y; Yamamoto M; Takeda Y; Minami K; Mataki H; Kanzaki T; Yamada K; Kanekura T; Akiyama S
    Int J Oncol; 2010 May; 36(5):1193-200. PubMed ID: 20372793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidine phosphorylase expression correlates with malignant potential and anti-tumor effect of doxifluridine on gastric cancer: multivariate analysis for adjuvant chemotherapy doxifluridine vs. 5-fluorouracil.
    Takiguchi N; Ishii R; Koda K; Oda K; Miyazaki M
    Oncol Rep; 2003; 10(5):1105-11. PubMed ID: 12883665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improved sensitivity of gastric carcinoma cells to fluorouracil-related drugs by transfection of thymidine phosphorylase gene].
    Zhuo LJ; Gao MQ; Huang AM
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):330-3. PubMed ID: 21756828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of thymidine phosphorylase levels in cancer, background mucosa, and regional lymph nodes on survival of advanced gastric cancer patients receiving postoperative fluoropyrimidine therapy.
    Kosaka T; Usami K; Ueshige N; Sugaya J; Nakano Y; Takashima S
    Oncol Rep; 2004 Dec; 12(6):1279-86. PubMed ID: 15547751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
    Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
    J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer.
    Ishii R; Takiguchi N; Oda K; Koda K; Miyazaki M
    Int J Oncol; 2001 Oct; 19(4):717-22. PubMed ID: 11562746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients.
    Amatori F; Di Paolo A; Del Tacca M; Fontanini G; Vannozzi F; Boldrini L; Bocci G; Lastella M; Danesi R
    Pharmacogenet Genomics; 2006 Nov; 16(11):809-16. PubMed ID: 17047489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of serum thymidine phosphorylase levels by highly sensitive enzyme-linked immunosorbent assay in gastric cancer.
    Katayanagi S; Aoki T; Takagi Y; Ito K; Sudo H; Tsuchida A; Koyanagi Y
    Oncol Rep; 2003; 10(1):115-9. PubMed ID: 12469155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
    Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymidine phosphorylase expression in invasive carcinoma: correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil.
    Yang Q; Shan L; Yoshimura G; Taniguchi E; Suzuma T; Nakamura Y; Nakamura M; Utsunomiya H; Tang W; Sakurai T; Kakudo K
    Anticancer Res; 1999; 19(6C):5543-6. PubMed ID: 10697613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enzymatic conversion of tegafur in human tumor tissue].
    Hara Y; Sugata S; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1511-7. PubMed ID: 6409007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H; Iinuma H; Watanabe T
    Oncol Rep; 2008 Mar; 19(3):729-35. PubMed ID: 18288408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.